Label Changes for:
Neurontin (gabapentin) capsules, tablets, and oral solution
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2011
Postmarketing and Other Experience
- breast enlargement